TSCA Chemical Testing; Receipt of Test Data
[Federal Register: January 10, 2006 (Volume 71, Number 6)]
[Notices]
[Page 1538-1540]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr10ja06-34]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
[EPA-HQ-OPPT-2003-0006; FRL-7746-6]
TSCA Chemical Testing; Receipt of Test Data
AGENCY: Environmental Protection Agency (EPA).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces EPA's receipt of test data regarding In
Vitro Dermal Absorption Rate Testing of Certain Chemicals of Interest
to the Occupational Safety and Health Administration. Data were
received on the following chemicals: Biphenyl (CAS No. 92-52-4); tert-
butylcatechol (TBC) (CAS No. 98-29-3); carbon disulfide (CAS No. 75-15-
0); catechol (CAS No. 120-80-9); chlorobenzene (CAS No. 108-90-7);
cyclohexanol (CAS No. 108-93-0); p-dichlorobenzene (CAS No. 106-46-7);
dimethylacetamide (DMAc) (CAS No. 127-19-5); ethylene dichloride (CAS
No. 107-06-2); hydroquinone monomethyl ether (HQMME) (CAS No. 150-76-
5); methyl formate (CAS No. 107-31-3); vinyl toluene (CAS No. 25013-15-
4); and p-xylene (CAS No. 106-42-3). These data were submitted pursuant
to a test rule issued by EPA under section 4 of the Toxic Substances
Control Act (TSCA).
FOR FURTHER INFORMATION CONTACT: Colby Lintner, Regulatory Coordinator,
Environmental Assistance Division (7408M), Office of Pollution
Prevention and Toxics, Environmental Protection Agency, 1200
Pennsylvania Ave., NW., Washington, DC 20460-0001; telephone number:
(202) 554-1404; e-mail address: TSCA-Hotline@epa.gov.
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this Action Apply to Me?
This action is directed to the public in general. This action may,
however, be of interest to those persons who are concerned about data
on health and/or environmental effects and other characteristics of
this chemical. Since other entities may also be interested, the Agency
has not attempted to describe all the specific entities that may be
affected by this action. If you have any questions regarding the
applicability of this action to a particular entity, consult the person
listed under FOR FURTHER INFORMATION CONTACT.
B. How Can I Get Copies of this Document and Other Related Information?
1. Docket. EPA has established an official public docket for this
action under docket identification (ID) number
[[Page 1539]]
EPA-HQ-OPPT-2003-0006. The official public docket consists of the
documents specifically referenced in this action, any public comments
received, and other information related to this action. Although a part
of the official docket, the public docket does not include Confidential
Business Information (CBI) or other information whose disclosure is
restricted by statute. The official public docket is the collection of
materials that is available for public viewing at the EPA Docket
Center, Rm. B102-Reading Room, EPA West, 1301 Constitution Ave., NW.,
Washington, DC. The EPA DocketCenter is open from 8:30 a.m. to 4:30
p.m., Monday through Friday, excluding legal holidays. The EPA Docket
Center Reading Room telephone number is (202) 566-1744 and the
telephone number for the OPPT Docket, which is located in EPA Docket
Center, is (202) 566-0280.
2. Electronic access. You may access this Federal Register document
electronically through the EPA Internet under the ``Federal Register''
listings at http://www.epa.gov/fedrgstr/.
Agency Website: EPADOCKET, EPA's electronic public docket and
comment system was replaced on November 25, 2005, by an enhanced
federal-wide electronic docket management and comment system located at
http://www.regulations.gov/. Follow the on-line instructions.
An electronic version of the public docket is available through
EPA's electronic public docket and comment system, EPA Dockets. You may
use EPA Dockets at http://www.epa.gov/edocket/ to submit or view public
comments, access the index listing of the contents of the official
public docket, and to access those documents in the public docket that
are available electronically. Although not all docket materials may be
available electronically, you may still access any of the publicly
available docket materials through the docket facility identified in
Unit I.B.1. Once in the system, select ``search,'' then key in the
appropriate docket ID number.
II. Test Data Submissions
Section 4(d) of TSCA requires EPA to publish a notice in the
Federal Register reporting the receipt of test data submitted pursuant
to test rules promulgated under section 4(a) within 15 days after these
data are received by EPA.
1. Test data for biphenyl were submitted by the Biphenyl Work
Group and received by EPA on June 17, 2005. The submission includes a
final study report submission titled: ``In Vitro Dermal Absorption Rate
Testing.'' (See document ID No. EPA-HQ-2003-0006-0273.) The submission
also includes a letter clarifying that the Biphenyl Work Group is not
claiming trade secrecy or confidentiality on this report.
2. Test data for TBC were submitted by the Tertiary-Butylcatechol
Consortium and received by EPA on July 20, 2005. The submission
includes a final report titled: ``[14C] Tert-Butylcatechol
(TBC): Percutaneous Penetration of [14C] Tert-Butylcatechol
Through Human Split-thickness Skin Membranes (in-vitro).'' (See
document ID No. EPA-HQ-2003-0006-0284.)
3. Test data for carbon disulfide were submitted by the Carbon
Disulfide Dermal Absorption Task Group (Task Group) of the American
Chemistry Council and received by EPA on August 15, 2005. The
submission includes an appended final study report titled: ``Carbon
Disulfide: In Vitro Dermal Absorption Rate Testing.'' (See document ID
No. EPA-HQ-2003-0006-0289.)
4. Test data on catechol were submitted by the Catechol Consortium
and received by EPA on August 26, 2005. The submission includes a final
study report titled ``[14C] Catechol: Percutaneous Penetration of [14C]
Catechol Through Human Split-thickness
Skin Membranes (in-vitro).'' (See document ID No. EPA-HQ-2003-0006-0287.)
5. Test data for chlorobenzene were submitted by the Chlorobenzene
Producers Association (CPA) and received by EPA on June 6, 2005. The
submission includes a final study report titled ``Chlorobenzene: In
Vitro Dermal Absorption Rate Testing.'' (See document ID No. EPA-HQ-
2003-0006-0255.)
6. Test data for cyclohexanol were submitted on behalf of the
Cyclohexanol Dermal Absorption Testing Committee and received by EPA on
August 29, 2005. The submission includes a final study report from
SafePharm Laboratories titled: ``The In Vitro Dermal Absorption of [14C]
Cyclohexanol through Human Skin.'' (See document ID
No. EPA-HQ-2003-0006-0286.)
7. Test data for p-dichlorobenzene were submitted by the
Chlorobenzene Producers Association and received by EPA on June 6,
2005. The submission includes a final study report titled: ``p-
Dichlorobenzene: In Vitro Dermal Absorption Rate Testing.'' (See
document ID No. EPA-HQ-2003-0006-0255.)
8. Test data for DMAc were submitted by DuPont Chemical Solutions
Enterprise and received by EPA on June 21, 2005. The submission
includes a final study report titled: ``Dimethylacetamide: In Vitro
Dermal Absorption Rate Testing.'' (See document ID No. EPA-HQ-2003-
0006-0274.)
9. Test data for ethylene dichloride were submitted by the
Hazardous Air Pollutant (HAP) Task Force and received by EPA on June
24, 2005. The submission includes a final study report titled:
``Ethylene Dichloride: In Vitro Dermal Absorption Rate Testing.'' (See
document ID No. EPA-HQ-2003-0006-0280.)
10. Test data for HQMME were submitted by the Hydroquinone
Monomethyl Ether Dermal Absorption Task Group (Task Group) of the
American Chemistry Council Hydroquinone Precursors and Derivatives
Panel, and received by EPA on September 27, 2005. The submission
includes an appended final study report titled: ``Hydroquinone
Monomethyl Ether: Measurement of the In Vitro Rate of Percutaneous
Absorption Through Human Skin.'' (See document ID No. EPA-HQ-2003-0006-
0293.)
11. Test data for methyl formate were submitted by Celanese
Chemicals and received by EPA on July 18, 2005. The submission includes
a final study report titled: ``Methyl Formate: In Vitro Dermal
Absorption Rate Testing.'' (See document ID Nos. EPA-HQ-2003-0006-0281
and EPA-HQ-2003-0006-0282.) The submission also includes a letter
clarifying that Celanese is not claiming confidentiality on this report.
12. Test data for vinyl toluene were submitted on behalf of
Deltech Corporation by the University of Louisiana and received by EPA
on April 4, 2005. The submission includes a final study report
submission titled: ``Vinyl Toluene: In Vitro Dermal Absorption Rate
Testing.'' (See document ID Nos. EPA-HQ-2003-0006-0247 and EPA-HQ-2003-
0006-0248.) The submission also includes two letters clarifying that
the study is not claimed confidential or trade secret.
13. Test data for p-xylene were submitted by the p-Xylene Dermal
Absorption Task Group of the American Chemistry Council and received by
EPA on September 27, 2005. The submission includes an appended final
study report titled: ``p-Xylene: In Vitro Dermal Absorption Rate
Testing.'' (See document ID No. EPA-HQ-2003-0006-0291.)
These chemical substances are used in a wide variety of
applications as industrial solvents, which may result in exposures of a
substantial number of workers as described in the support document for
the Proposed Rule (64 FR 31074,
[[Page 1540]]
June 9, 1999, Table 3 - Exposure Information for Chemical
Substances).
EPA has initiated its review and evaluation process for these
submissions. At this time, the Agency is unable to provide any
determination as to the completeness of the submissions.
Authority: 15 U.S.C. 2603.
List of Subjects
Environmental protection, Hazardous substances.
Dated: December 29, 2005.
Jim Willis,
Director, Chemical Control Division, Office of Pollution Prevention and
Toxics.
[FR Doc. E6-100 Filed 1-9-06; 8:45 am]
BILLING CODE 6560-50-S